Calcium channel blockers: the present and the future (original) (raw)
The role of calcium channel blockers in the treatment of hypertension
Luigi Cubeddu
American Heart Journal, 1986
View PDFchevron_right
Calcium channel blockers and hypertension
Allegra Battistoni
Journal of cardiovascular pharmacology and therapeutics, 2015
View PDFchevron_right
Use of Calcium Channel Blockers in Cardiovascular Risk Reduction
Julio Acosta
American Journal Cardiovascular Drugs, 2010
View PDFchevron_right
Efficacy and safety of the dual L- and T-type calcium channel blocker, ACT-280778: a proof-of-concept study in patients with mild-to-moderate essential hypertension
Jasper Dingemanse
Journal of human hypertension, 2015
View PDFchevron_right
Efficacy and safety of ACT-280778, a dual L- and T-type calcium channel blocker, in patients with mild-to-moderate essential hypertension: results from a phase 2a, randomized, double-blind, placebo- and active-controlled trial (REDUCE–1)
Jasper Dingemanse
View PDFchevron_right
Calcium antagonists: Not appropriate as first line antihypertensive agents
Curt Furberg
1996
View PDFchevron_right
Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175 634 patients
Caterina Marciano
Journal of Hypertension, 2009
View PDFchevron_right
A Calcium Antagonist vs a Non–Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery Disease
José Cangiano
JAMA, 2003
View PDFchevron_right
Comparison of two calcium blockers on hemodynamics, left ventricular mass, and coronary vasodilatory in advanced hypertension
Joseph Diamond
American journal of hypertension, 2001
View PDFchevron_right
Comparison of two calcium blockers on hemodynamics, left ventricular mass, and coronary vasodilatory in advanced hypertension* 1
Milena Henzlova
American journal of …, 2001
View PDFchevron_right
Efficacy and Safety of Dual Calcium Channel Blockade for the Treatment of Hypertension: A Meta-Analysis
A. Benjo
2013
View PDFchevron_right
Effectiveness and safety assessment of beta-blockers, calcium channel blockers, and angiotensin receptor blockers in hypertensive patients: a prospective study
Dhruvi Pandit
American journal of cardiovascular disease, 2021
View PDFchevron_right
Evolving role of calcium antagonists in themanagement of hypertension
Vito Campese
Medical Clinics of North America, 2004
View PDFchevron_right
Reduction of blood pressure by store-operated calcium channel blockers
Vijayan Elimban
Journal of cellular and molecular medicine, 2015
View PDFchevron_right
Calcium channel blockers in systemic hypertension
Jack A Stroh
The American Journal of Cardiology, 1986
View PDFchevron_right
Update on the use of calcium antagonists on hypertension
R. Hernández
Journal of Human Hypertension, 2002
View PDFchevron_right
Use of dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians: A scientific statement from the Asian Pacific Heart Association
Tzung-dau Wang
Hypertension Research, 2011
View PDFchevron_right
Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT
Luis Miguel
Lancet, 2000
View PDFchevron_right
Southwestern Internal Medicine Conference: Calcium Antagonists in the Treatment of Hypertension
Yoram Yagil
The American Journal of the Medical Sciences, 1985
View PDFchevron_right
How to Improve Effectiveness and Adherence to Antihypertensive Drug Therapy: Central Role of Dihydropyridinic Calcium Channel Blockers in Hypertension
Elisa Roca
High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2017
View PDFchevron_right
Management of Hypertension- Insights Into Real-World Clinical Practice for Differential Usage of Calcium Channel Blockers (CCBS)
Arup Dasbiswas
Journal of Evidence Based Medicine and Healthcare
View PDFchevron_right
Comparison of the Effect of Calcium Channel Blockers and Non-selective Beta-Blockers on Blood Lipids in Hypertensive Patients
Ghulam Murtaza
View PDFchevron_right
The pharmacological basis for the combination of calcium channel antagonists and angiotensin converting enzyme inhibitors in the treatment of hypertension
Bernd Mühlbauer
Journal of Hypertension, 1995
View PDFchevron_right
Current Treatment of Patients with Hypertension
Stefano Taddei
Drugs, 2003
View PDFchevron_right
Calcium Antagonists: Effects on Cardio-Renal Risk in Hypertensive Patients
Sandeep Nathan
Hypertension, 2005
View PDFchevron_right
Prospective study of calcium channel blocker use, cardiovascular disease, and total mortality among hypertensive women: the Nurses' Health Study
Alec Walker
Circulation, 1998
View PDFchevron_right
Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis
Lecteurs Sablon
View PDFchevron_right
Comparisons of Increasing Calcium Channel Blocker dose and Adding Thiazide Diuretic in Hypertensive Patients Given Medium-dose Angiotensin II Receptor Blocker and Amlodipine
Akihiro Tojo
Dokkyo journal of medical sciences, 2017
View PDFchevron_right
Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study
J. Lanke
Lancet, 2000
View PDFchevron_right